Infectious Pancreatic Necrosis is a highly contagious viral disease caused by a birnavirus that primarily affects young salmonid fish, causing significant mortality in fry and fingerling stages. First described in North American brook trout hatcheries during the 1940s, IPN has since been recognized worldwide as one of the most economically important viral diseases affecting the aquaculture industry. The virus targets the pancreas and associated digestive tissues, causing characteristic necrosis that gives the disease its name, though the pathology extends to other organ systems as well. IPN is notable for its ability to establish persistent carrier states in surviving fish, creating ongoing challenges for disease control in affected facilities.
The disease affects a broad range of salmonid species including rainbow trout, Atlantic salmon, brook trout, brown trout, and various Pacific salmon species, with fry and early juvenile stages being most susceptible to acute disease and high mortality. Beyond salmonids, the IPN virus has been isolated from numerous non-salmonid freshwater and marine fish species, indicating an extremely wide potential host range, though clinical disease in these other species is less consistently documented. The global distribution of IPNV across aquaculture facilities and wild fish populations on every continent makes it one of the most widespread fish pathogens known.
The impact of IPN on aquaculture operations can be substantial, with acute outbreaks in young fish causing mortality rates that may exceed ninety percent in severely affected populations. In Atlantic salmon aquaculture, a distinct clinical syndrome affecting post-smolt fish during their first months in seawater causes significant losses and has driven major industry investment in disease research and control measures. Beyond direct mortality, IPN causes economic losses through reduced growth rates in survivors, costs of implementing biosecurity measures, trade restrictions on fish from affected areas, and the challenges of managing carrier fish that can transmit virus to naive populations.
While no cure exists for IPN, significant advances have been made in disease prevention and management. Selective breeding programs have developed Atlantic salmon strains with increased resistance to IPN, dramatically reducing losses in some regions. Vaccines are available and provide partial protection, though they do not prevent infection or eliminate carrier states. Strict biosecurity measures and testing programs can reduce virus introduction and spread. Understanding the biology of IPN virus, its complex epidemiology, and the factors influencing disease expression is essential for effective management in aquaculture operations handling susceptible species.
